Integrating Omic Technologies in Alzheimer's Disease

Area of Science:

• Biomedical Sciences
• Systems Biology
• Omics Sciences

Background:

• Precision medicine leverages unique patient traits for tailored therapies.
• Reductionism, a traditional biomedical approach, is insufficient for complex diseases like Alzheimer's.
• Alzheimer's Disease (AD) presents molecular complexities and heterogeneity challenging the "one disease, one drug" model.

Purpose of the Study:

• To explore recent advances in omics and systems biology for understanding Alzheimer's Disease.
• To advocate for a paradigm shift in Alzheimer's research beyond reductionist approaches.
• To emphasize the role of high-throughput omics strategies in unraveling AD pathogenesis.

Main Methods:

• Review of recent advances in omics field and systems biology.
• Analysis of high-throughput strategies applied to omics sciences.
• Exploration of molecular pathogenesis and disease heterogeneity in Alzheimer's.

Main Results:

• Omics and systems biology offer a more comprehensive understanding of AD.
• High-throughput strategies are crucial for advancing AD research.
• Current understanding of AD pathogenesis is limited by reductionist models.

Conclusions:

• A systems biology approach is essential for a complete understanding of Alzheimer's Disease.
• High-throughput omics strategies are paramount for future Alzheimer's research.
• Rethinking traditional models is necessary for effective Alzheimer's disease management and therapy development.